Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pranshul Sethi

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Molecules (Basel, Switzerland)|June 24, 2022
Activation of IGF-1/GLP-1 Signalling via 4-Hydroxyisoleucine Prevents Motor Neuron Impairments in Experimental ALS-Rats Exposed to Methylmercury-Induced NeurotoxicityAmbika Shandilya, Sidharth Mehan, Sumit Kumar, et al.
Current Stem Cell Research & Therapy|June 17, 2025
Exploring the Dual Roles of Neural Stem Cells in Glioblastoma: Therapeutic Implications and OpportunitiesKuldeep Singh, Pranshul Sethi, Jeetendra Kumar Gupta, et al.
Brain Sciences|March 25, 2022
Smo-Shh Agonist Purmorphamine Prevents Neurobehavioral and Neurochemical Defects in 8-OH-DPAT-Induced Experimental Model of Obsessive-Compulsive DisorderRia Gupta, Sidharth Mehan, Pranshul Sethi, et al.
Current Topics in Medicinal Chemistry|August 7, 2024
Recent Advances in the Synthesis of Antioxidant Derivatives: Pharmacological Insights for Neurological DisordersKuldeep Singh, Jeetendra Kumar Gupta, Pranshul Sethi, et al.
Current Neuropharmacology|June 9, 2026
Targeting α-Synuclein Aggregation in Parkinson's Disease: A Narrative Review of Current Gene Therapy StrategiesKuldeep Singh, Pranshul Sethi, Divya Jain, et al.
CNS & Neurological Disorders Drug Targets|February 27, 2026
Insights into the Molecular Mechanisms of Neurodegenerative Diseases: Exploring Molecular Pathways and the Therapeutic Potential of RivastigmineKuldeep Singh, Pranshul Sethi, Mamta Kumari, et al.
Current Topics in Medicinal Chemistry|May 19, 2026
Molecular Mechanisms of Neurodegeneration: A Focus on Cholinergic Dysfunction and the Therapeutic Potential of Rivastigmine DerivativesKuldeep Singh, Pranshul Sethi, Divya Jain, et al.
European Journal of Pharmacology|August 8, 2024
Emerging pharmacological approaches for Huntington's diseaseKuldeep Singh, Divya Jain, Pranshul Sethi, et al.
Current Neuropharmacology|April 6, 2026
Advances in the Synthesis of GABAergic Modulators for Anxiety and Depression: Pathways and Potential ApplicationsKuldeep Singh, Pranshul Sethi, Divya Jain, et al.
Pharmaceutics|August 29, 2024
Recent Review on Biological Barriers and Host-Material Interfaces in Precision Drug Delivery: Advancement in Biomaterial Engineering for Better Treatment TherapiesRohitas Deshmukh, Pranshul Sethi, Bhupendra Singh, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Molecules (Basel, Switzerland)|June 24, 2022
Activation of IGF-1/GLP-1 Signalling via 4-Hydroxyisoleucine Prevents Motor Neuron Impairments in Experimental ALS-Rats Exposed to Methylmercury-Induced NeurotoxicityAmbika Shandilya, Sidharth Mehan, Sumit Kumar, et al.
Current Stem Cell Research & Therapy|June 17, 2025
Exploring the Dual Roles of Neural Stem Cells in Glioblastoma: Therapeutic Implications and OpportunitiesKuldeep Singh, Pranshul Sethi, Jeetendra Kumar Gupta, et al.
Brain Sciences|March 25, 2022
Smo-Shh Agonist Purmorphamine Prevents Neurobehavioral and Neurochemical Defects in 8-OH-DPAT-Induced Experimental Model of Obsessive-Compulsive DisorderRia Gupta, Sidharth Mehan, Pranshul Sethi, et al.
Current Topics in Medicinal Chemistry|August 7, 2024
Recent Advances in the Synthesis of Antioxidant Derivatives: Pharmacological Insights for Neurological DisordersKuldeep Singh, Jeetendra Kumar Gupta, Pranshul Sethi, et al.
Current Neuropharmacology|June 9, 2026
Targeting α-Synuclein Aggregation in Parkinson's Disease: A Narrative Review of Current Gene Therapy StrategiesKuldeep Singh, Pranshul Sethi, Divya Jain, et al.
CNS & Neurological Disorders Drug Targets|February 27, 2026
Insights into the Molecular Mechanisms of Neurodegenerative Diseases: Exploring Molecular Pathways and the Therapeutic Potential of RivastigmineKuldeep Singh, Pranshul Sethi, Mamta Kumari, et al.
Current Topics in Medicinal Chemistry|May 19, 2026
Molecular Mechanisms of Neurodegeneration: A Focus on Cholinergic Dysfunction and the Therapeutic Potential of Rivastigmine DerivativesKuldeep Singh, Pranshul Sethi, Divya Jain, et al.
European Journal of Pharmacology|August 8, 2024
Emerging pharmacological approaches for Huntington's diseaseKuldeep Singh, Divya Jain, Pranshul Sethi, et al.
Current Neuropharmacology|April 6, 2026
Advances in the Synthesis of GABAergic Modulators for Anxiety and Depression: Pathways and Potential ApplicationsKuldeep Singh, Pranshul Sethi, Divya Jain, et al.
Pharmaceutics|August 29, 2024
Recent Review on Biological Barriers and Host-Material Interfaces in Precision Drug Delivery: Advancement in Biomaterial Engineering for Better Treatment TherapiesRohitas Deshmukh, Pranshul Sethi, Bhupendra Singh, et al.
Pageof 3